| 0.7001 Data as of May 22 |  -0.0074 / -1.05%Today’s Change | 0.38 Today|||52-Week Range 0.83 | +40.16% Year-to-Date |
| Narrower than Expected Loss at Infinity - Analyst Blog May 09 / Zacks.com |
| Previous close | 0.71 |
| Today’s open | 0.72 |
| Day’s range | -- - -- |
| Volume | 2,016,265 |
| Average volume (3 months) | 1,812,802 |
| Market cap | $126.0M |
| Dividend yield | -- |
| Earnings growth (last year) | -16.67% |
| Earnings growth (this year) | -8.57% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -57.95% |
| P/E ratio | NM |
| Price/Sales | 16.56 |
| Price/Book | 2.94 |
| Today’s change | Today’s % change | |
|---|---|---|
| GERNGeron Corp | -0.02 | -1.79% |
| TROVTrovagene Inc | -0.50 | -7.31% |
| --Medytox Solutions In... | 0.00 | 0.00% |
| PATHNupathe Inc | -0.01 | -0.32% |
| Last reporting date | May 15, 2013 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $4.1M |
| Annual profit (last year) | -$19.7M |
| Net profit margin | -477.56% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director J. Joseph Kim, PhD, MBA |
Chief Operating Officer Niranjan Y. Sardesai, PhD, MBA |
Corporate headquarters Blue Bell, Pennsylvania |
.
